Filter

Refine by collections

  • Thyroid (2)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 2 of 2 items for :

  • methylation x
Clear All
Hui Li Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, P. R. China.

Search for other papers by Hui Li in
Google Scholar
PubMed Close
and
Peng Wu Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, P. R. China.

Search for other papers by Peng Wu in
Google Scholar
PubMed Close

various diseases, including thyroid cancer ( 3 , 4 ). This regulation includes DNA methylation, chromatin remodeling, histone modifications, and the expression of diverse non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long ncRNAs (lncRNAs), and

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-24-0087
Volume/Issue:
Volume 13: Issue 9
Open access
Camila Aparecida Moma Endocrinology Division, Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

Search for other papers by Camila Aparecida Moma in
Google Scholar
PubMed Close
,
Icléia Siqueira Barreto Department of Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

Search for other papers by Icléia Siqueira Barreto in
Google Scholar
PubMed Close
,
Ligia Vera Montali Assumpção Endocrinology Division, Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

Search for other papers by Ligia Vera Montali Assumpção in
Google Scholar
PubMed Close
, and
Denise Engelbrecht Zantut-Wittmann Endocrinology Division, Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

Search for other papers by Denise Engelbrecht Zantut-Wittmann in
Google Scholar
PubMed Close

( 7 ). The main driver mutations appear in the BRAF and RAS genes, leading to deregulation in MAPK pathway signaling, resulting in distinct clinicopathological characteristics and different gene expression and DNA methylation profiles ( 8

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-24-0135
Volume/Issue:
Volume 13: Issue 8
Open access